TPIDB > Principal Investigator
Principal Investigator
更新時間：2023-09-19
胡瑞恒HU, REY-HENG
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
19Publications
1
Ho CM, Lee CH, Lee MC, Zhang JF, Chen CH, Wang JY, Hu RH, Lee PH. Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis. Front Oncol. 2021 Jan 28;10:616094. doi: 10.3389/fonc.2020.616094.
2
Chiang YT, Lin TH, Hu RH, Lee PC, Shih HC. Predicting factors for major trauma patient mortality analyzed from trauma registry system. Asian J Surg. 2021 Jan;44(1):262-268. doi: 10.1016/j.asjsur.2020.06.014. Epub 2020 Aug 25.
3
Hsiao CY, Ho MC, Ho CM, Wu YM, Lee PH, Hu RH. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. J Pers Med. 2021 Feb 1;11(2):90. doi: 10.3390/jpm11020090.
4
Chen HM, Shih FJ, Hu RH, Shih FJ, Sheu SJ. Comparing the different viewpoints on overseas transplantation demands between genders and roles. Medicine (Baltimore). 2021 Jan 8;100(1):e23650. doi: 10.1097/MD.0000000000023650.
5
Ho CM, Wang JY, Yeh CC, Hu RH, Lee PH. Experience of applying threshold concepts in medical education. J Formos Med Assoc. 2021 Apr;120(4):1121-1126. doi: 10.1016/j.jfma.2020.09.008. Epub 2020 Sep 19.
6
Lin CH, Ho CM, Wu CH, Liang PC, Wu YM, Hu RH, Lee PH, Ho MC. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis. Surg Endosc. 2020 Dec;34(12):5566-5573. doi: 10.1007/s00464-019-07357-x. Epub 2020 Jan 28.
7
Shen YC, Hsu CL, Jeng YM, Ho MC, Ho CM, Yeh CP, Yeh CY, Hsu MC, Hu RH, Cheng AL. Reliability of a single-region sample to evaluate tumor immune microenvironment in hepatocellular carcinoma. J Hepatol. 2020 Mar;72(3):489-497. doi: 10.1016/j.jhep.2019.09.032. Epub 2019 Oct 18. PMID: 31634533.
8
Ho CM, Hu RH, Lee PH. Significance of Offspring Donors on Long-term Survival in Adult Living Donor Liver Transplantation: Asian Experience. Transplantation. 2020 Oct;104(10):e306. doi: 10.1097/TP.0000000000003351. PMID: 32969990.
9
Hsiao CY, Hu RH, Ho CM, Wu YM, Lee PH, Ho MC. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study. Am J Surg. 2020 Oct;220(4):958-964. doi: 10.1016/j.amjsurg.2020.03.017. Epub 2020 Mar 25. PMID: 32247523.
10
Ho CM, Hu RH, Wu YM, Ho MC, Lee PH. Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation. Clin Med Insights Oncol. 2020 Dec 9;14:1179554920968774. doi: 10.1177/1179554920968774. PMID: 33343205; PMCID: PMC7731698.
1
2
